State Prescription Drug Affordability Board bills gain momentum in Connecticut and Rhode Island; Virginia bill still awaits action by Governor YoungkinLegislation that would create drug pricing review boards continues to advance at the state level, evidence that state...
February is make or break time for Congressional budget negotiations…and we’re already behind on the 2025 processThanks to another round of the legendary “kick the can” game, the federal government did not shut down in January. Congress managed to pass a short-term...
Feds Release Top 10 Medicare Part D Drugs List; More Lawsuits Filed Against Inflation Reduction Act (IRA) The Centers for Medicare & Medicaid Services (CMS) released its long-awaited list of the first 10 Medicare Part D drugs that will be subject to negotiation...
When it comes to value in pricing, it is not about greed.Many associations think that if they discuss pricing, their members will see them as greedy, especially because we are nonprofit organizations. The reality is that our pricing is directly related to our...
“When it comes to pricing and value propositions for our association’s products, do our competitors matter?” That’s the question that we’re going to tackle in this article. For most associations, their number one pricing strategy is to analyze their...
Recent Comments